TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Combined nasal symptom and medication score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma lipase level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hospital readmission rate (all-cause)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Fatigue resistance
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Algorithm efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor and non-motor symptoms of Parkinson's disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Voice test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chemotherapy-induced neuropathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Vocal Range Profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of follicles recruited
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Access to virtual care for preventive services
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Engagement in virtual care for preventive services
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Functional impact of stress
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Area under the plasma concentration - time curve of rosuvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Event densities
Endpoint domain: Mortality/survival
Primary endpoint: Interest in missed period pills
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Satisfaction with missed period pills
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Profiling Elements of Prosodic Systems in Children
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pragmatic Skills in the Medea Language
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Test for understanding emotions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Movement Assessment Battery for Children - Second Edition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Children's Communication Checklist - Second Edition
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Proportion of AVT06 injections successfully administered
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of ocular TEAEs, AESIs, and SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Investigator's Global Assessment (IGA) score of 0/1 at Week 16
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eczema Area and Severity Index (EASI 75) at Week 16
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of women still breastfeeding
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: complete pathologic response (pCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change from Baseline in Gross Motor Function Measure (GMFM-88)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Functional Independence Measure (FIM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Bristolian Scale (BS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Constipation Severity Scale (CSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change from Baseline in Sleep Form in Children (SFC)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Report generation time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change of cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change of fasting sugar from blood sample
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change of insulin from blood sample
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Visual Field- Mean Deviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Visual Field- Visual Field Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Improvement in renal function progression rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Procedural and investigational product-related treatment-emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: MD Anderson Dysphagia Index (MDADI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Contraction Frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lymphatic system outcomes
Primary endpoint: Packet Velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lymphatic system outcomes
Primary endpoint: Pumping Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lymphatic system outcomes
Primary endpoint: Compliance with wearable technology
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Complete tumor response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change from Baseline Centre Of Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time above range 180 mg/dl
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Urinary activin A levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Proportion of appropriate prophylaxis rate during hospitalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Proportion of participants who developed the VTE (all, symptomatic, asymptomatic VTE)
Endpoint domain: Adverse events/effects
Primary endpoint: Presence of yellow fever 17D virus in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Solicited local and systemic reactions after administration of each dose of the vaccine
Endpoint domain: Adverse events/effects
Primary endpoint: Unsolicited adverse events after each vaccine dose
Endpoint domain: Adverse events/effects
Primary endpoint: Vital capacity of the lungs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Forced vital capacity of the lungs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Forced expiratory volume of the lungs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Forced expiratory volume percent of the lungs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Peak expiratory flow of the lungs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: R0 removal rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in muscle activity of hip extensor muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in muscle activity of back extensor muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: FEV (Forced Expiratory Volume)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percentage of patients with extended treatment interval
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Severity of caregiver burden
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: 24h AUC of Nutren Diabetes group with Fresubin Diabetes group
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of developing diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of developing pre diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: HSS score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: KSS scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Occurrence of all SAEs and AEs related to study procedure
Endpoint domain: Adverse events/effects
Primary endpoint: Gingival inflammation measured by Gingival Index (GI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Oral health outcomes
Primary endpoint: Gingival inflammation measured by Gingival bleeding index (GBI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Oral health outcomes
Primary endpoint: Changes in isokinetic peak torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in muscle contractile characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: severity of coronary disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of Injection Procedures With Successful Completions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage of Injection Procedures With Use Errors
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants who experience one or more common terminology criteria for adverse events (CTCAE) grade ≥ 3 adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Global Impression of Perceived Difficulties (GIPD) assessment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: glutamine synthetase levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of repaired restoration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of severe Acute exacerbation of COPD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Lung function decline over time (FEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Health care resource utilization in AECOPD
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Blood pressure agreement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Post-operative top downhill walking speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention Rate Percentage
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in lesion response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: MRI-PDFF intraperitoneal fat content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Numbers of participants with nonunion
Endpoint domain: Adverse events/effects
Primary endpoint: MMR (BCR/ABL IS < 0.1%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of moderate or severe functional tricuspid regurgitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total incidence frequency of progression to moderate COVID-19 illness or worse
Endpoint domain: Mortality/survival
Primary endpoint: Median time to a stable decrease in the total score on the COVID-19 Major Symptom Rating Scale to ≤ 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: modified Rankin Scale score (mRS) 0 to 2 at 90 days
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: SFO-OLVT functional connectivity (z-score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Plasma arginine vasopressin concentration (pg/mL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Opioid misuse assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Penkid levels at KRT initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Penkid levels at discontinuation of KRT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of post induction hypotension
Endpoint domain: Adverse events/effects
Primary endpoint: Pittsburgh Sleep Quality Scale (PSQI)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Prevalence of obsessive-compulsive disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of calls completed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Satisfaction with treatments
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Readiness to change marijuana use
Endpoint domain: Life impact
Endpoint subdomain: Behavioral outcomes
Primary endpoint: Bupivacaine-Exparel levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time weighted average of area under hypotensive threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Alterations of gut metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Serum Chromium Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Efficacy of L-TC treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distribution of injected fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Richmond agitation sedation score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak Nicotine Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean overall systemic nicotine exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Mean score on the Modified Cigarette Evaluation Questionnaire (mCEQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Kidney allograft loss
Endpoint domain: Mortality/survival
Primary endpoint: Number of solicited and unsolicited adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Upper limb functional Index (ULFI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Satisfaction with Breasts
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Duration of auditory-verbal hallucinations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Digital Assessment Completion Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: NB-SCT Program Adherence
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Total number of participants who complete the intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Surgical Site Infection - Superficial Incisional
Endpoint domain: Adverse events/effects
Primary endpoint: Surgical Site Infection - Deep Incisional
Endpoint domain: Adverse events/effects
Primary endpoint: Surgical Site Infection - Organ/Space Incisional
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of subjects completely lice free
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in atherosclerotic plaque burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Total Antioxidant Capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Renal damage markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Long term effect of COVID-19 on liver function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Body Dysmorphic Disorder Modification of the Yale-Brown Obsessive Compulsive Disorder Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hip joint range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective visual vertical test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Software malfunction occurrences
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of maternal transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Feasibility of eHA tool
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability of eHA tool
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Usability of eHA tool
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Completion of PET/CT scans
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Radiological signs of pulmonary infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Proportion of patients not coughing during postoperative extubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of new drug
Endpoint domain: Adverse events/effects
Primary endpoint: microbiological concordance on donor's BAL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pressure-time product of the esophageal pressure per minute
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biomarkers for predicting outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Range of motion (ROM) of the diseased knee
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence rate of drug allergy
Endpoint domain: Adverse events/effects
Primary endpoint: SUVmax measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WI-NRS score improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Feeding Oral Motor scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Self-reported rumination related to negative affect
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Average pain in the first week after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clearance of infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Months of treatment with medication for opioid use disorder
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Median Intracranial Progression-free survival (icPFS)
Endpoint domain: Mortality/survival
Primary endpoint: Changes in Eating Disorder Examination scale score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Quality of life scores change
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in perceptions of neighborhood collective efficacy
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change in perceptions of community cohesion
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change in Dentin Hypersensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of pressure injury
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Score on the Brief Test of Adult Cognition by Telephone (BTACT)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Score on the Metamemory in Adulthood Questionnaire-Revised
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Recurrence of Atrial Tachycardia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to Recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Illicit Opioid Use Over Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Initiation of Medications for OUD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Emergency Department visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Number of participants with flap failure
Endpoint domain: Adverse events/effects
Primary endpoint: Increased risk of infection
Endpoint domain: Adverse events/effects
Primary endpoint: Complications up to 3 months post
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline in Meibomian Gland Dysfunction Dry Eye symptom score (MGD-DE) at 14 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospitalary stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Change in understanding
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Hamilton Rating for Depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mood Assessment Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline in mean Hamilton Depression Rating Scale score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline in mean Insomnia Severity Index score
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change from the Self-Rating Depression Scale (SDS) at week 12
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing